Among patients with GCA, those with low vs high CRP levels more often presented with anterior ischemic optic neuropathy and limb claudication.

In a recent column, you answered a question regarding weight loss. You stated that you do not recommend weight-loss drugs unless the person is very overweight or has ...

Recently in America more than 1,800 lawsuits have been filed against the makers of semaglutide, including Ozempic. HELLO!

In celebration of Ophthalmology Times ' 50th anniversary, we asked leading experts in the field, in a perfect world, if they ...

Explore the implications of the rising popularity of weight loss drugs like Semaglutide, their misuse on social media, and ...

A new study published in the Journal of American Medical Association found that the use of glucagon-like peptide-1 receptor ...

ZUG, Switzerland, Aug. 21, 2025 (GLOBE NEWSWIRE) -- <li /> Focused execution in Q2 2025 to advance Oculis' pipeline in ophthalmology and ...

A small percentage of patients on injectable weight loss drugs such as Ozempic and Wegovy experienced permanent vision loss, according to a new study. The report, published Thursday in the medical ...

Pharmaceutical companies behind weight loss and diabetes medication such as Ozempic are facing a lawsuit that could potentially pay out more than $2 billion. There is multidistrict litigation, or an ...

Pharmaceutical companies behind weight loss and diabetes medication such as Ozempic are facing a lawsuit that could potentially pay out more than $2 billion. Rating: Mostly True (About this rating?) ...

Some studies link GLP-1 use to an increased risk for ocular diseases such as nonarteritic anterior ischemic optic neuropathy (NAION), diabetic retinopathy, papillitis, and optic nerve disorders. A new ...